Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kenneth Maiese

Showing results (81-90 of 231) with videos related to

Pageof 24
Sort By:
Current Neurovascular Research|September 24, 2014
Turning up the pressure on vascular diseaseKenneth Maiese
Current Neurovascular Research|September 16, 2014
WISP1: Clinical insights for a proliferative and restorative member of the CCN familyKenneth Maiese
World Journal of Diabetes|October 31, 2015
Erythropoietin and diabetes mellitusKenneth Maiese
British Journal of Clinical Pharmacology|October 16, 2015
Targeting molecules to medicine with mTOR, autophagy and neurodegenerative disordersKenneth Maiese
Biochemical Society Transactions|March 11, 2018
The mechanistic target of rapamycin (mTOR) and the silent mating-type information regulation 2 homolog 1 (SIRT1): oversight for neurodegenerative disordersKenneth Maiese
Neural Regeneration Research|January 29, 2019
Impacting dementia and cognitive loss with innovative strategies: mechanistic target of rapamycin, clock genes, circular non-coding ribonucleic acids, and Rho/RockKenneth Maiese
Expert Review of Clinical Pharmacology|December 4, 2019
Cognitive impairment with diabetes mellitus and metabolic disease: innovative insights with the mechanistic target of rapamycin and circadian clock gene pathwaysKenneth Maiese
Current Neurovascular Research|October 27, 2023
Microglia: Formidable Players in Alzheimer's Disease and Other Neurodegenerative DisordersKenneth Maiese
Current Neurovascular Research|December 24, 2021
The Oversight of Circadian Clock Genes for the Detection, Prevention, and Treatment of COVID-19 InfectionKenneth Maiese
Current Neurovascular Research|February 10, 2022
A Common Link in Neurovascular Regenerative Pathways: Protein Kinase B (Akt)Kenneth Maiese
Pageof 24

Showing results (81-90 of 231) with videos related to

Sort By:
Pageof 24
Current Neurovascular Research|September 24, 2014
Turning up the pressure on vascular diseaseKenneth Maiese
Current Neurovascular Research|September 16, 2014
WISP1: Clinical insights for a proliferative and restorative member of the CCN familyKenneth Maiese
World Journal of Diabetes|October 31, 2015
Erythropoietin and diabetes mellitusKenneth Maiese
British Journal of Clinical Pharmacology|October 16, 2015
Targeting molecules to medicine with mTOR, autophagy and neurodegenerative disordersKenneth Maiese
Biochemical Society Transactions|March 11, 2018
The mechanistic target of rapamycin (mTOR) and the silent mating-type information regulation 2 homolog 1 (SIRT1): oversight for neurodegenerative disordersKenneth Maiese
Neural Regeneration Research|January 29, 2019
Impacting dementia and cognitive loss with innovative strategies: mechanistic target of rapamycin, clock genes, circular non-coding ribonucleic acids, and Rho/RockKenneth Maiese
Expert Review of Clinical Pharmacology|December 4, 2019
Cognitive impairment with diabetes mellitus and metabolic disease: innovative insights with the mechanistic target of rapamycin and circadian clock gene pathwaysKenneth Maiese
Current Neurovascular Research|October 27, 2023
Microglia: Formidable Players in Alzheimer's Disease and Other Neurodegenerative DisordersKenneth Maiese
Current Neurovascular Research|December 24, 2021
The Oversight of Circadian Clock Genes for the Detection, Prevention, and Treatment of COVID-19 InfectionKenneth Maiese
Current Neurovascular Research|February 10, 2022
A Common Link in Neurovascular Regenerative Pathways: Protein Kinase B (Akt)Kenneth Maiese
Pageof 24